SCHEMBL7320628

SCHEMBL7320628

CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C(CS)Cc1ccccc1)C(=O)O

nearest known ligand 0.93

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MME P08473 6/20 0.93

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2679035 0.96 MME (1.00) MME
SCHEMBL8249769 0.96 MME (1.00) MME
SCHEMBL5869271 0.96 MME (1.00) MME
SCHEMBL2679032 0.96 MME (1.00) MME
SCHEMBL5869412 0.96 MME (1.00) MME
SCHEMBL8861738 0.90 MME (0.88) MME
SCHEMBL8861742 0.90 MME (0.88) MME
SCHEMBL9751225 0.88 MME (0.81) MME
SCHEMBL9068522 0.88 MME (0.81) MME
SCHEMBL7435294 0.87 MME (0.87) MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5262436-A Administering; enzyme inhibitor SCHERING CORPORATION (US) 1993-11-16 US disclosed
EP-0566157-A1 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1993-10-20 EP disclosed
US-5061710-A Atrial natriuretic factors SCHERING CORPORATION (US) 1991-10-29 US disclosed
US-4929641-A DIURETICS, ANGIOTENSIN CONVERTING ENZYMES SCHERING CORPORATION (US) 1990-05-29 US disclosed
US-4801609-A Mercapto-acylamino acid antihypertensives SCHERING CORPORATION (US) 1989-01-31 US disclosed
EP-0254032-A2 Neutral metalloendopeptidase inhibitors in the treatment of hypertension SCHERING CORPORATION (US) 1988-01-27 EP disclosed